INS and neoplasm: In particular, cultured cells do not benefit from the indirect anti-tumor effects of MET occurring in vivo such as the reduction of insulin levels—where insulin is known to have a mitogenic effect—and cultured cells are exposed to high concentrations of growth factors and glucose present in the culture medium, which may help explain the required higher doses of MET [41].